Centrum Kompleksowej Rehabilitacji

Konstancin-Jeziorna 05-510

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis — Completed
• Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) — Stopped early